Carta científica
Utilidad de etomidato en paciente con síndrome de Cushing con hipertensión arterial e hipopotasemia graves
Usefulness of ethomidate in patients with Cushing syndrome with severe arterial hypertension and hypopotassemia
Leído
15123
Vecesse ha leído el artículo
4296
Total PDF
10827
Total HTML
| año/Mes | Html | Total | |
|---|---|---|---|
| 2025 6 | 6 | 3 | 9 |
| 2025 5 | 147 | 59 | 206 |
| 2025 4 | 139 | 45 | 184 |
| 2025 3 | 154 | 50 | 204 |
| 2025 2 | 138 | 43 | 181 |
| 2025 1 | 124 | 57 | 181 |
| 2024 12 | 89 | 49 | 138 |
| 2024 11 | 93 | 56 | 149 |
| 2024 10 | 167 | 76 | 243 |
| 2024 9 | 120 | 61 | 181 |
| 2024 8 | 162 | 60 | 222 |
| 2024 7 | 121 | 41 | 162 |
| 2024 6 | 139 | 108 | 247 |
| 2024 5 | 158 | 69 | 227 |
| 2024 4 | 161 | 55 | 216 |
| 2024 3 | 117 | 48 | 165 |
| 2024 2 | 156 | 37 | 193 |
| 2024 1 | 162 | 55 | 217 |
| 2023 12 | 119 | 59 | 178 |
| 2023 11 | 147 | 70 | 217 |
| 2023 10 | 182 | 54 | 236 |
| 2023 9 | 119 | 60 | 179 |
| 2023 8 | 100 | 40 | 140 |
| 2023 7 | 130 | 67 | 197 |
| 2023 6 | 129 | 42 | 171 |
| 2023 5 | 128 | 68 | 196 |
| 2023 4 | 93 | 37 | 130 |
| 2023 3 | 135 | 62 | 197 |
| 2023 2 | 116 | 60 | 176 |
| 2022 1 | 136 | 54 | 190 |
| 2022 12 | 146 | 62 | 208 |
| 2022 11 | 135 | 73 | 208 |
| 2022 10 | 175 | 70 | 245 |
| 2022 9 | 151 | 67 | 218 |
| 2022 8 | 123 | 72 | 195 |
| 2022 7 | 130 | 49 | 179 |
| 2022 6 | 100 | 42 | 142 |
| 2022 5 | 125 | 56 | 181 |
| 2022 4 | 136 | 70 | 206 |
| 2022 3 | 96 | 60 | 156 |
| 2022 2 | 127 | 51 | 178 |
| 2021 1 | 127 | 44 | 171 |
| 2021 12 | 98 | 58 | 156 |
| 2021 11 | 124 | 55 | 179 |
| 2021 10 | 110 | 79 | 189 |
| 2021 9 | 85 | 44 | 129 |
| 2021 8 | 116 | 72 | 188 |
| 2021 7 | 73 | 37 | 110 |
| 2021 6 | 90 | 27 | 117 |
| 2021 5 | 95 | 65 | 160 |
| 2021 4 | 252 | 106 | 358 |
| 2021 3 | 143 | 54 | 197 |
| 2021 2 | 116 | 28 | 144 |
| 2020 1 | 98 | 23 | 121 |
| 2020 12 | 99 | 20 | 119 |
| 2020 11 | 118 | 26 | 144 |
| 2020 10 | 71 | 33 | 104 |
| 2020 9 | 106 | 33 | 139 |
| 2020 8 | 88 | 25 | 113 |
| 2020 7 | 98 | 34 | 132 |
| 2020 6 | 75 | 23 | 98 |
| 2020 5 | 80 | 16 | 96 |
| 2020 4 | 117 | 29 | 146 |
| 2020 3 | 73 | 24 | 97 |
| 2020 2 | 146 | 68 | 214 |
| 2020 1 | 106 | 29 | 135 |
| 2019 12 | 135 | 34 | 169 |
| 2019 11 | 152 | 60 | 212 |
| 2019 10 | 122 | 36 | 158 |
| 2019 9 | 75 | 41 | 116 |
| 2019 8 | 78 | 33 | 111 |
| 2019 7 | 67 | 36 | 103 |
| 2019 6 | 66 | 19 | 85 |
| 2019 5 | 91 | 50 | 141 |
| 2019 4 | 68 | 33 | 101 |
| 2019 3 | 61 | 33 | 94 |
| 2019 2 | 54 | 34 | 88 |
| 2019 1 | 71 | 36 | 107 |
| 2018 12 | 115 | 50 | 165 |
| 2018 11 | 293 | 98 | 391 |
| 2018 10 | 247 | 30 | 277 |
| 2018 9 | 101 | 16 | 117 |
| 2018 8 | 66 | 25 | 91 |
| 2018 7 | 64 | 18 | 82 |
| 2018 6 | 107 | 30 | 137 |
| 2018 5 | 57 | 19 | 76 |
| 2018 4 | 130 | 18 | 148 |
| 2018 3 | 122 | 19 | 141 |
| 2018 2 | 83 | 22 | 105 |
| 2018 1 | 87 | 54 | 141 |
| 2017 12 | 91 | 30 | 121 |
| 2017 11 | 80 | 25 | 105 |
| 2017 10 | 69 | 1 | 70 |
| 2017 9 | 9 | 1 | 10 |
| 2017 8 | 2 | 2 | 4 |
| 2017 7 | 20 | 12 | 32 |
| 2017 6 | 3 | 9 | 12 |
| 2017 5 | 6 | 0 | 6 |
| 2017 4 | 0 | 1 | 1 |
| 2016 12 | 0 | 2 | 2 |
Mostrar todo
